These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 2928937)
1. High resolution 10B and 11B nuclear magnetic resonance (NMR) spectroscopy of Na2B12H11SH impurities and metabolites. Samsel EG; Miller DL Strahlenther Onkol; 1989; 165(2-3):140-1. PubMed ID: 2928937 [No Abstract] [Full Text] [Related]
2. Biomedical applications of 10B and 11B NMR. Bendel P NMR Biomed; 2005 Apr; 18(2):74-82. PubMed ID: 15770608 [TBL] [Abstract][Full Text] [Related]
3. 11B nuclear magnetic resonance studies of the interaction of borocaptate sodium with serum albumin. Tang PP; Schweizer MP; Bradshaw KM; Bauer WF Biochem Pharmacol; 1995 Mar; 49(5):625-32. PubMed ID: 7887977 [TBL] [Abstract][Full Text] [Related]
4. Analysis of 10B antitumoral compounds by means of flow-injection into ESI-MS/MS. Basilico F; Sauerwein W; Pozzi F; Wittig A; Moss R; Mauri PL J Mass Spectrom; 2005 Dec; 40(12):1546-9. PubMed ID: 16320299 [TBL] [Abstract][Full Text] [Related]
5. The compound factor of the 10B(n,alpha)7Li reaction from borocaptate sodium and the relative biological effectiveness of recoil protons for induction of brain damage in boron neutron capture therapy. Gabel D; Philipp KH; Wheeler FJ; Huiskamp R Radiat Res; 1998 Apr; 149(4):378-86. PubMed ID: 9525503 [TBL] [Abstract][Full Text] [Related]
6. New direct 11B NMR-based analysis of organoboranes through their potassium borohydrides. Medina JR; Cruz G; Cabrera CR; Soderquist JA J Org Chem; 2003 Jun; 68(12):4631-42. PubMed ID: 12790565 [TBL] [Abstract][Full Text] [Related]
7. Boron neutron capture therapy: boron biodistribution and pharmacokinetics of Na2B12H11SH in patients with glioblastoma. Haselsberger K; Radner H; Pendl G Cancer Res; 1994 Dec; 54(24):6318-20. PubMed ID: 7987820 [TBL] [Abstract][Full Text] [Related]
8. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy. Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904 [TBL] [Abstract][Full Text] [Related]
9. Biodistribution of boron in dogs with spontaneous intracranial tumors following borocaptate sodium administration. Kraft SL; Gavin PR; Leathers CW; DeHaan CE; Bauer WF; Miller DL; Dorn RV; Griebenow ML Cancer Res; 1994 Mar; 54(5):1259-63. PubMed ID: 8118814 [TBL] [Abstract][Full Text] [Related]
10. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT). Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412 [TBL] [Abstract][Full Text] [Related]
11. Gross boron determination in biological samples by inductively coupled plasma-atomic emission spectroscopy. Bauer WF; Johnson DA; Steele SM; Messick K; Miller DL; Propp WA Strahlenther Onkol; 1989; 165(2-3):176-9. PubMed ID: 2928943 [No Abstract] [Full Text] [Related]
12. Quantitative structure-property relationships in boron nitrides: the 15N- and 11B chemical shifts. Marian CM; Gastreich M Solid State Nucl Magn Reson; 2001; 19(1-2):29-44. PubMed ID: 11407601 [TBL] [Abstract][Full Text] [Related]
13. [Kinetics of the cell population of transplantable murine B-16 melanoma after administration of mercaptoundecahydrododecaborate enriched with 10B]. Shabalkin IP; Spryshkova RA; Serebriakov NG Med Radiol (Mosk); 1985 Nov; 30(11):32-4. PubMed ID: 4068942 [TBL] [Abstract][Full Text] [Related]
15. Multi-nuclear MRS and 19F MRI of 19F-labelled and 10B-enriched p-boronophenylalanine-fructose complex to optimize boron neutron capture therapy: phantom studies at high magnetic fields. Porcari P; Capuani S; Campanella R; La Bella A; Migneco LM; Maraviglia B Phys Med Biol; 2006 Jun; 51(12):3141-54. PubMed ID: 16757868 [TBL] [Abstract][Full Text] [Related]
16. A bystander effect observed in boron neutron capture therapy: a study of the induction of mutations in the HPRT locus. Kinashi Y; Masunaga S; Nagata K; Suzuki M; Takahashi S; Ono K Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):508-14. PubMed ID: 17418970 [TBL] [Abstract][Full Text] [Related]
17. Nuclear Overhauser effect (NOE) enhancement of 11B NMR spectra of borane adducts in the solid state. Ashbrook SE; Dowell NG; Prokes I; Wimperis S J Am Chem Soc; 2006 May; 128(21):6782-3. PubMed ID: 16719446 [TBL] [Abstract][Full Text] [Related]
18. Boron analysis and boron imaging in biological materials for Boron Neutron Capture Therapy (BNCT). Wittig A; Michel J; Moss RL; Stecher-Rasmussen F; Arlinghaus HF; Bendel P; Mauri PL; Altieri S; Hilger R; Salvadori PA; Menichetti L; Zamenhof R; Sauerwein WA Crit Rev Oncol Hematol; 2008 Oct; 68(1):66-90. PubMed ID: 18439836 [TBL] [Abstract][Full Text] [Related]
19. In vivo tissue analysis by NMR spectroscopy. den Hollander JA Diagn Imaging Clin Med; 1986; 55(1-2):9-19. PubMed ID: 3011347 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and tissue distribution of the sulfhydryl boranes (monomer and dimer) in glioma-bearing rats. Joel D; Slatkin D; Fairchild R; Micca P; Nawrocky M Strahlenther Onkol; 1989; 165(2-3):167-70. PubMed ID: 2928940 [No Abstract] [Full Text] [Related] [Next] [New Search]